Evidence map›Paper›PMID 32452644›Full record

ArticleAndrology2021

Caution in the management of SARS-CoV-2 infection in males.

Luca De Toni, Andrea Garolla, Andrea Di Nisio, Maria Santa Rocca, Carlo Foresta

Open access · bronzeAbstract read
In one paragraph

Article in Andrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Luca De ToniUnit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.ORCID 0000-0003-4958-5217
Andrea GarollaUnit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.ORCID 0000-0003-4736-9051
Andrea Di NisioUnit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.ORCID 0000-0002-7251-9210
Maria Santa RoccaUnit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.ORCID 0000-0002-4794-9745
Carlo ForestaUnit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy.ORCID 0000-0002-6576-2183
University of Padua · IT

Funding

Fondazione Cassa di Risparmio di Padova e Rovigo - Bando di Ricerca Covid 2019 55813
6 · The paper itself

Abstract

The coronavirus 2 (SARS-CoV-2) pandemic carries clinical, economic, and social burdens that are currently being disclosed. The key steps of virus life cycle have been recently clarified, highlighting the role of host type 2 angiotensin-converting enzyme (ACE2) and TMPRSS2 serine protease in virus-cell binding and entry, respectively. Importantly, major concerns derive from the androgen-dependent tissue-expression of both TMPRSS2 and ACE2, suggesting a differential clinical course of the infection between genders. In agreement with this model, available epidemiological data show that the disease in males has an higher risk to display an heavier pattern and associates with both an increased access to critical care unit and higher mortality rate. In this opinion article, available evidence linking the androgen activity with the gender differences observed in SARS-CoV-2 infection are discussed, hypothesizing possible therapeutic approaches in male based on the disruption of androgen signaling. On these bases, gender-specific recommendations for the management of male patients affected by SARS-CoV-2 infection are warmly suggested, in order to improve the clinical course of the disease.

Indexed as

Health Status DisparitiesAndrogensAngiotensin-Converting Enzyme 2AnimalsCOVID-19FemaleHost-Pathogen InteractionsHumansMaleReceptors, VirusRisk FactorsSARS-CoV-2Serine EndopeptidasesSex FactorsACE2 protein, humanAndrogensAngiotensin-Converting Enzyme 2Receptors, VirusSerine EndopeptidasesTMPRSS2 protein, humanACE2androgensgendermalesSARS-Cov-2TMPRSS2

Identifiers

PMID32452644
PMCPMC7283787
OpenAlexW3031523519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.